Literature DB >> 21192309

Remodeling of C2 facet deformity prevents recurrent subluxation in patients with chronic atlantoaxial rotatory fixation: a novel strategy for treatment of chronic atlantoaxial rotatory fixation.

Ken Ishii1, Morio Matsumoto, Suketaka Momoshima, Kota Watanabe, Takashi Tsuji, Hironari Takaishi, Masaya Nakamura, Yoshiaki Toyama, Kazuhiro Chiba.   

Abstract

STUDY
DESIGN: A retrospective case series.
OBJECTIVE: To propose a novel treatment strategy for chronic atlantoaxial rotatory fixation (AARF). SUMMARY OF BACKGROUND DATA: Treatment strategy for chronic or recurrent AARF remains controversial. We have previously reported that a deformity of the superior facet of the axis (C2 facet deformity), which is frequently observed in patients with chronic AARFs, is a risk factor for recurrent dislocation. In this article, we report seven consecutive cases of chronic AARF who underwent closed manipulation followed by external halo fixation and maintained good reduction with the remodeling of the C2 facet deformity.
METHODS: Seven girls with a chronic AARF who sustained torticollis for an average of 4.6 months after the onset were referred to our clinic. Closed manipulation by careful manipulation under general anesthesia followed by external immobilization with a halo vest was performed in all cases. Radiographic findings and clinical courses were retrospectively reviewed with approvals by the institutional review board.
RESULTS: Three-dimensional computed tomography images before reduction revealed persistent atlantoaxial subluxation and the C2 facet deformity in the dislocated side in all cases. Follow-up three-dimensional computed tomographic scans demonstrated the remodeling of the C2 facet deformity at an average of 2.8 months after successful reduction of subluxation. Subsequently, the halo vests were removed and gentle neck range of motion exercise was started in all cases. The normal cervical range of motion was obtained 2 weeks after the removal of halo vests in five cases, whereas the range of motion remained limited in two cases. At a mean follow-up of 17.4 months, neither symptoms nor recurrence of subluxation occurred in all cases.
CONCLUSION: Chronic irreducible and recurrent unstable AARF can be managed successfully by careful closed manipulation followed by halo fixation, if the C1 and C2 have not been osseously fused. The remodeling of the C2 facet deformity detected on follow-up CT scans can be a useful radiographic parameter to determine the appropriate period of halo fixation in this new treatment strategy obviating the need for surgical intervention.

Entities:  

Mesh:

Year:  2011        PMID: 21192309     DOI: 10.1097/BRS.0b013e3181d8bbdd

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  4 in total

1.  Atlantoaxial rotatory dislocation (AARD) in pediatric age: MRI study on conservative treatment with Philadelphia collar--experience of nine consecutive cases.

Authors:  Alessandro Landi; Andrea Pietrantonio; Nicola Marotta; Cristina Mancarella; Roberto Delfini
Journal:  Eur Spine J       Date:  2012-03-13       Impact factor: 3.134

2.  Spontaneous Ankylosis of Occiput to C2 following Closed Traction and Halo Treatment of Atlantoaxial Rotary Fixation.

Authors:  Walter F Krengel; Paul H Kim; Brett Wiater
Journal:  Global Spine J       Date:  2015-06

Review 3.  C1-C2 Rotatory Subluxation in Adults "A Narrative Review".

Authors:  David C Noriega González; Francisco Ardura Aragón; Jesús Crespo Sanjuan; Silvia Santiago Maniega; Alejandro León Andrino; Rubén García Fraile; Gregorio Labrador Hernández; Juan Calabia-Campo; Alberto Caballero-García; Alfredo Córdova-Martínez
Journal:  Diagnostics (Basel)       Date:  2022-07-02

4.  Spontaneous Osseous Fusion after Remodeling Therapy for Chronic Atlantoaxial Rotatory Fixation and Recovery Mechanism of Rotatory Range of Motion of the Cervical Spine.

Authors:  Kazuya Kitamura; Ken Ishii; Narihito Nagoshi; Kazuhiro Chiba; Morio Matsumoto; Masaya Nakamura; Kota Watanabe
Journal:  J Clin Med       Date:  2022-03-09       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.